이양순
2018-04-16T04:08:05Z
2018-04-16T04:08:05Z
2012-03
Yonsei Medical Journal, 2012, 53(2), P.439-441
0513-5796
1976-2437
https://synapse.koreamed.org/DOIx.php?id=10.3349/ymj.2012.53.2.439
We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotrophomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trimethoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most of the isolates tested. Moxifloxacin and tigecycline were also active and hold promise as therapeutic options for S. maltophilia infections.
This research was supported by the Happy Tech. Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant number 20110004679).
en
Yonsei Univ Coll Medicine
Antimicrobial susceptibility
Levofoxacin
Minocycline
Stenotrophomonas maltophilia
Trime-thoprim-sulfamethoxazole
Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from a Korean Tertiary Care Hospital
Article
53
10.3349/ymj.2012.53.2.439
439-441
YONSEI MEDICAL JOURNAL
Chung, H.-S.
Hong, S.G
Lee, K.
Lee, Y.
Kim, M.
Yong, D.
Jeong, S.H.
Chong, Y.
2012209912
S
COLLEGE OF MEDICINE[S]
DEPARTMENT OF MEDICINE
yangsoon